Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients

Experimental Dermatology

Volumn 8, Issue 1, 1999, Pages 39-45

  Rukwied, R ^a   Heyer, G ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Acetylcholine; Atopic eczema; Cetirizine; Pruritus

Indexed keywords

ACETYLCHOLINE; CETIRIZINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DRUG EFFECT; EVOKED RESPONSE; FEMALE; HUMAN; IMAGE ANALYSIS; INTRADERMAL DRUG ADMINISTRATION; MALE; MEDIATOR RELEASE; MICRODIALYSIS; PRURITUS; RATING SCALE; STIMULUS RESPONSE; SWEATING;

EID: 0032907666     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1999.tb00346.x     Document Type: Article

References (40)

1. Hanifin J M. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy 1986: 4(1): 43-65.
2. Fahrenkrug J. VIP as a Neurotransmitter in the Peripheral Nervous System. Vasoactive Intestinal Peptide. In: Said S I, ed. New York: Raven Press, 1982: 361-372.
3. Hartschuh W, Weihe E, Reinecke M. Peptidergic (neurotensin, VIP, substance P) nerve libres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation. Br J Dermatol 1983: 109 (Suppl 25): 14-17.
4. Lundberg J M, Anggard A, Fahrenkrug J, Hökfelt T, Mutt V. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: Functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci USA 1980: 77: 1651-1655.
5. Lindh B, Hökfelt T. Structural and functional aspects of acetylcholine peptide coexistence in the autonomic nervous system. Prog Brain Res 1990: 84: 175-191.
6. Giannetti A, Fantini F, Cimitan A, Pincelli C. Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992: 176: 90-92.
7. Scott A. Acetylcholine in normal and diseased skin. Br J Dermatol 1962: 74: 317-322.
8. Vogelsang M, Heyer G, Hornstein O P. Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects. Acta Derm Venereol 1995: 75(6): 434-436.
9. Nischik M, Forster C. Analysis of skin erythema using true color images. IEEE Trans Med Imaging 1997: 16(6): 711-716.
10. Rukwied R, Nischik M, Forster C, Heyer G, Handwerker H O. Flare responses of atopic eczema patients analysed with true colour images. Inflamm Res 1997: 46: 336-341.
11. Petersen L J, Skov P S. Methacholine induces wheal-and-flare reactions in human skin but does not release histamine in vivo as assessed by the skin microdialysis technique. J Allergy Clin Immunol 1995: 50: 976-980.
12. Hanifin J M, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980: 92: 44-47.
13. Nischik M, Forster C, Handwerker H O. The thermal image in medicine and biology. In: Ammer K, Ring E F J, eds. Analysis of vascular skin reactions using superimposed video and thermal images. Wien: Uhlen-Verlag, 1995: 130-135.
14. Piotrowski W, Foreman J C. On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedebergs Arch Pharmacol 1985: 331(4): 364-368.
15. Fjellner B, Hägermark O. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 1981: 61(3): 245-250.
16. Heyer G, Rukwied R. Itch sensation and vasoreaction after vasoactive intestinal peptide and acetylcholine. [Abstract] J Invest Dermatol 1996: 106(4): 932.
17. Cutz E, Chan W, Track N S, Goth A, Said S I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 1978: 275(5681): 661-662.
18. Uehara M. Reduced histamine reaction in atopic dermatitis. Arch Dermatol 1982: 118(4): 244-245.
19. Heyer G, Hornstein O P, Handwerker H O. Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 1989: 93(4): 492-496.
20. Heyer G, Hornstein O P, Hardwerker H O. Reactions to intradermally injected Substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm Venereol (Stockh) 1991: 71: 291-295.
21. Koppert W, Heyer G, Handwerker H O. Atopic eczema and histamine-induced sensations. Dermatology 1996: 192: 227-232.
22. Heinz-Erian P, Paul S, Said S I. Receptors for vasoactive intestinal peptide on isolated human sweat glands. Peptides 1986: 7 (Suppl 1): 151-154.
23. Kummer W, Herbst W M, Heym C. Vasoactive intestinal polypeptide receptor-like immunoreactivity in human sweat glands. Neurosci Lett 1990: 110(3): 239-243.
24. Herbst W M. Localization of vasoactive intestinal polypeptide receptor in human skin. Z Hautkr 1991: 66(1): 46-48.
25. Wallengren J, Möller H, Ekman R. Occurrence of substance P, vasoactive intestinal peptide, and calcitonin generelated peptide in dermographism and cold urticaria. Arch Dermatol Res 1987: 279(8): 512-515.
26. Pincelli C, Fantini F, Romualdi P, Lesa G, Giannetti A. Skin levels of vasoactive intestinal polypeptide in atopic dermatitis. Arch Dermatol Res 1991: 283(4): 230-232.
27. Klapproth H, Reinheimer T, Metzen J et al. Non-neuronal acetylcholine, a signalling molecule synthesized by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol 1997: 355: 515-523.
28. Handwerker H O, Magerl W, Klemm F, Lang E, Westermann R A. Fine afferent nerve fibers and pain. In: Schmidt R F, Schaible H-G, Vahle-Hinz C, eds. Quantitative evaluation of itch sensation. Weinheim: VCH Verlagsgesellschaft, 1987: 461-473.
29. Schmelz M, Schmidt R, Bickel A, Handwerker H O, Torebjörk H E. Specific C-receptors for itch in human skin. J Neurosci 1997: 17(20): 8003-8008.
30. Wahlgren C F, Tengvall Linder M, Hägermark O, Scheynius A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995: 287(6): 572-580.
31. Horsmanheimo L, Harvima I T, Jarvikallio A, Harvima R J, Naukkarinen A, Horsmanheimo M. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994: 131(3): 348-353.
32. Gabrielsson S, Paulie S, Rak S et al. Specific induction of interleukin-4-producing cells in response to in vitro allergen stimulation in atopic individuals. Clin Exp Allergy 1997: 27: 808-815.
33. Marshall J S, Waserman S. Mast cells and the nerves -potential interactions in the context of chronic disease. Clin Exp Dermatol 1995: 25(2): 102-110.
34. Hornquist R, Bäck O. Henriksson R. Adrenoreceptor-mediated responses in human skin studied by iontophoresis. Br J Dermatol 1984: 111: 561-566.
35. Copeman P W M, Winkelmann R K. Vascular changes accompanying white dermographismus and delayed blanch in atopic dermatitis. Br J Dermatol 1969: 81: 944-945.
36. Ryan T J. Vascular reactivity in atopic eczema. In: Ruzicka T, Ring J, Przybilla B. eds. Handbook of Atopic Eczema. Berlin, Heidelberg, New York: Springer-Verlag, 1991: 263-277.
37. Grando S A. Biological functions of keratinocyte cholinergic receptors. Symposium Proceedings. J Invest Dermatol 1997: 2: 41-48.
38. 1-receptor antagonists: clinical pharmacology. Clin Exp Dermatol 1990: 20 (Suppl 2): 19-24.
39. Müller F O, Botha J J, van Dyk M, Luus H G, Groenewoud G. Attenuation of cutaneous reactivity to histamine by cetirizine and dexchlorpheniramine. Eur J Clin Pharmacol 1988: 35(3): 319-321.
40. Juhlin L, Michaelsson G. Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol 1969: 49(3): 251-261.